Skip to main content
MED logo

MED · Medifast Inc

Track MED — free
$11.95 +0.33 (+2.84%) At close · Aug 21
Market Cap
$133.61M
Shares
11.18M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$385.79M -36%
FY2025 Revenue FY2009–FY2025
Net Income
-$18.67M -993%
FY2025 Net Income FY2009–FY2025
Gross Margin
71.33% -2.5pp
FY2025 Gross Margin FY2009–FY2025
Operating Margin
-3.68% -4.2pp
FY2025 Operating Margin FY2009–FY2025
Diluted EPS
-$1.70 -994.7%
FY2025 Diluted EPS FY2009–FY2025
Operating Cash Flow
$6.86M -72%
FY2025 Operating Cash Flow FY2009–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
$270M – $300M $316.93M $385.79M $602.46M $1.07BG $1.6B $1.53B $934.84M $713.67M $501M $301.56M $274.53M $272.77M $285.29M $324.05M $318.57M $298.19M $257.55M $169.74M
$97.48M $110.6M $157.84M $296.2M $458.16M $398.49M $237.03M $176.81M $121.1M $73.75M $68.87M $71.46M $76.08M $83.49M $82.66M $73.69M $65.08M $45.36M
$219.45M $275.19M $444.62M $775.85M $1.14B $1.13B $697.82M $536.86M $379.9M $227.81M $205.66M $201.32M $209.21M $240.57M $235.91M $224.5M $192.47M $124.39M
71.33% 73.8% 72.37% 71.34% 73.89% 74.65% 75.22% 75.83% 75.54% 74.91% 73.8% 73.33% 74.24% 74.05% 75.29% 74.73% 73.28%
$4.3M $4.6M $4.6M $4.5M $4.4M $2.8M $2.7M $2.2M $1.5M $2M $1.8M $1.3M
$238.96M $289.4M $441.75M $649.45M $955.61M $911.36M $563.66M $445.82M $310.84M $188.18M $178.81M $172.63M $178.96M $202.16M $208.77M $197.11M $160.83M $105.89M
$428K $572K $456K
$14.24M $12.71M $13.11M $10.98M $6.81M $4.32M $4.62M $4.44M $4.21M $5.41M $7.12M $8.05M $7.9M $8.39M $8.34M $5.86M $5.27M
$1.34M
-$19.51M -$14.21M $2.88M $126.4M $184.81M $216.24M $134.16M $91.04M $69.06M $39.63M $26.86M $28.68M $30.25M $38.41M $27.14M $27.38M $31.64M $18.5M
-3.68% 0.48% 11.79% 11.56% 14.17% 14.35% 12.76% 13.78% 13.14% 9.78% 10.52% 10.6% 11.85% 8.52% 9.18% 12.28% 10.9%
$29K $15.59M $139.51M $195.79M $223.05M $138.48M $95.66M $73.5M $43.84M $32.26M $35.8M $38.3M $46.31M $35.53M $35.73M $37.5M $23.76M
$102K $111K $145K
$5.54M $8.57M $909K $2.4M -$747K -$112K $106K $1.32M $1.49M $694K $263K $987K $1.45M $633K $1.22M $298K $52K -$73K
-$13.97M -$5.64M $3.79M $128.8M $184.06M $216.13M $134.27M $92.36M $70.55M $40.33M $27.12M $29.67M $31.69M $39.04M $28.36M $27.68M $31.69M $18.42M
$11.63M $13.03M $1.7M $29.38M $40.49M $52.1M $31.41M $14.45M $14.76M $12.61M $9.29M $10.1M $10.66M $11.91M $9.91M $9.14M $12.08M $7.07M
-$25.6M -$18.67M $2.09M $99.42M $143.57M $164.03M $102.86M $77.92M $55.79M $27.72M $17.84M $20.06M $13.18M $23.97M $15.88M $18.54M $19.61M $11.36M
-4.84% 0.35% 9.27% 8.98% 10.75% 11% 10.92% 11.14% 9.19% 6.5% 7.35% 4.62% 7.4% 4.98% 6.22% 7.61% 6.69%
-$25.77M -$18.62M $2.02M $99.64M $143.48M $164.1M $102.88M $78.11M $55.78M $27.73M $17.73M $19.56M $12.91M $24.12M $16.03M $18.7M $19.69M $11.91M
USD/shares -$1.70 $0.19 $9.13 $12.82 $14.01 $8.74 $6.62 $4.67 $2.32 $1.51 $1.68 $1.04 $1.74 $1.16 $1.33 $1.39 $0.84
USD/shares -$1.70 $0.19 $9.10G $12.73 $13.89 $8.68 $6.43 $4.62 $2.29 $1.49 $1.66 $1.03 $1.73 $1.16 $1.31 $1.35 $0.77
shares 10.98M 10.93M 10.88M 11.2M 11.71M 11.77M 11.77M 11.95M 11.92M 11.84M 11.96M 12.67M 13.77M 13.72M 13.97M 14.08M 13.52M
shares 10.98M 10.96M 10.92M 11.28M 11.81M 11.85M 12.12M 12.08M 12.09M 11.95M 12.07M 12.78M 13.82M 13.74M 14.2M 14.57M 14.74M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $341.94M in buybacks, $348.43M in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Personal Services median 1.64×
EV/EBIT
Personal Services median 14.34×
P/E (TTM)
Personal Services median 21.75×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022
Optavia Segment $385,788,000 $602,463,000 $1,072,054,000 $1,598,577,000
Key facts CIK 910329 CUSIP 58470H101 13F (30d) 111 filings 104 filers Visit website Investor relations